21st Austria weekly - Marinomed (07/02/2024)

21st Austria weekly - Marinomed 07/02/2024 [pic1]Marinomed: Biotech AG has enrolled the first patient in a clinical study to investigate lubricating properties of Carragelose eye drops patients diagnosed with mild moderate dry disease. While product holds valid certification under Medical Device Directive MDD supports switch new Regulation MDR. are planned launch 2024. Furthermore business development process for partnering outside is full swing. Next drops also allergen-blocking nasal spray published data demonstrating effectiveness prophylactic treatment allergic rhinitis symptoms nose on pre-print server October

Related Keywords

Austria , Mexico , Zumtobel Gruppe , Zumtobel , International Journal , Procter Gamble , Marinomed Biotech , Medical Device Directive , Medical Device Regulation , Besuchen Sie , Ic1 Marinomed , Marinomed , Biotech , Bag , Carragelose , Awhile , Medical , Device , Directive , Mmdd , Regulation , Cmdr , Furthermore , Next , October ,